 4. Patients who have thrombosis, serious cardiac, pulmonary, renal, gastrointestinal, hepatic, immunologic, infectious, neoplastic with particular focus on patients with known or suspected estrogen or testosterone-dependent tumors, or urologic disease with a particular focus on patients with a history of prostatic hypertrophynodules. 